Literature DB >> 2850756

Single-dose oral fluconazole in the treatment of vaginal candidosis.

K W Brammer1, J M Feczko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2850756     DOI： 10.1111/j.1749-6632.1988.tb40452.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Effect of oral antacid administration on the pharmacokinetics of oral fluconazole.

Authors:  J E Thorpe; N Baker; M Bromet-Petit
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

2.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  1-[2-(2,6-Dichloro-benz-yloxy)-2-(2-fur-yl)eth-yl]-1H-benzimidazole.

Authors:  Ozden Ozel Güven; Taner Erdoğan; Simon J Coles; Tuncer Hökelek
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-07-09

Review 4.  Pharmacokinetic optimisation of oral antifungal therapy.

Authors:  M Schäfer-Korting
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

5.  Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis.

Authors:  E T Houang; O Chappatte; D Byrne; P V Macrae; J E Thorpe
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  New treatments for vulvovaginal candidiasis.

Authors:  S Faro
Journal:  Infect Dis Obstet Gynecol       Date:  1996

7.  Systemic vs. topical therapy for the treatment of Vulvovaginal Candidiasis.

Authors:  S Faro
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.